The Experience of the Child With Cancer When Port à Cath Needle : Child's Speech

This qualitative research refers to the descriptive phenomenological method of Hurssel which allows an analysis of the experience and an understanding of the phenomenon. Semi-structured interviews are carried out with 10 children followed for cancer in 3 pediatric hemato-oncology departments. The children interviewed are aged 6 to 12 and can be with their parents. A thematic analysis approach is used to analyze the data of this research.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Pediatric Oncology Neoplasms

Age range

6 year–12 year

Sex eligibility

All sexes

Study type

Observational

Primary location

CHU clermont-ferrand

Clermont-Ferrand, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Child followed in pediatric oncology for cancer or hematological disease
Child wearing a Port-a-cath needle placement and minimum use once a week

Exclusion criteria

Child no speaking the French language

Treatment and study plan

Primary outcomes

Experience of self management of port-a-cath needle placement

Time frame: 60 minutes

Evaluation from the patients' point of view on how they self-manage a port a cath needle placement, semi-structured qualitative interviews with patients.

Sponsors and collaborators

Lead sponsor

University Hospital, Clermont-Ferrand

Other

Registry information

Acronym: ELEAPort

Important dates

Study start: 2022
Primary completion: 2022
Study completion: 2022
First posted: Jan 20, 2023
Registry last updated: Jan 20, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed